Article Text

Download PDFPDF

91 The relation between thyroid dysfunction and mortality in patients with chronic heart failure
  1. Nathan Samuel1,
  2. Joseph Cuthbert2,
  3. Oliver Brown2,
  4. Syed Kazmi2,
  5. John GF Cleland3,
  6. Alan Rigby1,
  7. Andrew Clark2
  1. 1Hull York Medical School
  2. 2Department of Academic Cardiology, Hull York Medical School
  3. 3Robertson Centre for Biostatistics


Introduction Thyroid dysfunction is common in patients with chronic heart failure (CHF), but there is conflicting evidence regarding its prognostic significance. We investigated the relation between thyroid dysfunction and prognosis in a large, well characterised cohort of ambulatory patients with CHF.

Methods Heart failure was defined as signs and symptoms of the disease and either left ventricular systolic dysfunction (LVSD) mild or worse (heart failure with reduced ejection fraction (HeFREF)), or no LVSD and raised amino-terminal pro-B-type natriuretic peptide (NT-proBNP) levels (>125 ng/L) (heart failure with normal ejection fraction (HeFNEF)). Euthyroid was defined as a TSH level between 0.35–4.70 mIU/l, hypothyroidism as >4.70 mIU/L, and hyperthyroidism as <0.35 mIU/L. The primary outcome was all-cause mortality.

Results 2997 patients had HeFREF and 1995 patients had HeFNEF. 4491 (90.0%) patients were euthyroid, 312 (6.3%) were hypothyroid, and 189 (3.8%) were hyperthyroid (Table 1). In univariable analysis, both hypothyroid patients (hazard ratio (HR) 1.25, 95% confidence interval (CI) 1.08 to 1.45) and hyperthyroid patients (HR 1.21, 95% CI 1.01 to 1.46) had a greater risk of death compared to euthyroid patients (Figure 1). There was a U-shaped relation between TSH and outcome (Figure 2). Increasing TSH was a predictor of mortality in univariable analysis (HR 1.02, 95% CI 1.01 to 1.03), but the association disappeared in multivariable analysis (Table 2). The three strongest predictors of adverse outcome were age, increasing NT-proBNP, and higher NYHA class.

Abstract 91 Table 1

Demographics, clinical characteristics and pharmacological treatment of patients with heart failure according to thyroid status

Abstract 91 Table 2

Univariable and multivariable analysis for all-cause mortality in all patients with heart failure

Abstract 91 Figure 1

Relation between TSH and probability of death at 5 years

Abstract 91 Figure 2

Kaplan-Meier survival curve for all-cause mortality stratified by thyroid status

Conclusion Although thyroid dysfunction is associated with worse survival in patients with CHF, it is not an independent predictor of mortality.

Conflict of Interest None

  • TSH
  • thyroid dysfunction
  • heart failure

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.